GenVec Inc. is no longer in violation of Nasdaq's listing requirements.
The company regained compliance after its stock price hovered above $1 for 10 consecutive days.
Discover more about S&P Global’s offerings
GenVec regains Nasdaq listing compliance
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
GenVec Inc. is no longer in violation of Nasdaq's listing requirements.
The company regained compliance after its stock price hovered above $1 for 10 consecutive days.